Impairment and Restructuring Charges

12 Months Ended

Dec. 31, 2019

Restructuring and Related Activities [Abstract]

On December 31, 2019, the Company completed substantially the previously announced wind down of the operations of the Health Integrated business, which is reported within the Healthcare reportable segment. The operating results of this business were significantly below the Company's estimates and actual cash flows were impacted due to loss of customer contracts and cost pressures, and the Company incurred losses from this business. The commencement of the process of winding down the Health Integrated business was previously disclosed by the Company in the Current Report on Form 8-K filed with the Securities and Exchange Commission (“SEC”) on April 4, 2019 as amended by a Current Report on Form 8-K/A filed with the SEC on July 16, 2019. In connection with the wind down process, the Company recorded pre-tax costs in the consolidated statements of income under “Impairment and restructuring charges”.

The following table summarizes the activity related to the restructuring costs incurred and paid for the wind down during the year ended December 31, 2019:



	Contract Termination Costs			Employee-Related Costs			Other Associated Costs			Total
Balance as of January 1, 2019	$	—		$	—		$	—		$	—
Costs incurred during the year	2,597			1,375			1,072			5,044
Payments during the year	(1,000		)	(269		)	(701		)	(1,970		)
Balance as of December 31, 2019	$	1,597		$	1,106		$	371		$	3,074

Additionally, the Company recognized impairment of ROU assets and long-lived assets of $3,627 during the year ended December 31, 2019 in the consolidated statements of income under "Impairment and restructuring charges".